Widespread shortening of 3′UTRs by alternative cleavage and polyadenylation activates oncogenes in cancer cells
Name
Bartel_Widespread shortening.pdf
Size
1.98 MB
Format
Adobe PDF
Checksum (MD5)
e8242522b90b257956b945c82500e7fe
Author(s)
Mayr, Christine
Bartel, David
Date Issued
August 2009
Journal
Cell
Publisher
Elsevier
Citation
Mayr, Christine, and David P. Bartel. “Widespread Shortening of 3′UTRs by Alternative Cleavage and Polyadenylation Activates Oncogenes in Cancer Cells.” Cell 138.4 (2009): 673–684.
Version
Author's final manuscript
Abstract
In cancer cells, genetic alterations can activate proto-oncogenes, thereby contributing to tumorigenesis. However, the protein products of oncogenes are sometimes overexpressed without alteration of the proto-oncogene. Helping to explain this phenomenon, we found that when compared to similarly proliferating nontransformed cell lines, cancer cell lines often expressed substantial amounts of mRNA isoforms with shorter 3′ untranslated regions (UTRs). These shorter isoforms usually resulted from alternative cleavage and polyadenylation (APA). The APA had functional consequences, with the shorter mRNA isoforms exhibiting increased stability and typically producing ten-fold more protein, in part through the loss of microRNA-mediated repression. Moreover, expression of the shorter mRNA isoform of the proto-oncogene IGF2BP1/IMP-1 led to far more oncogenic transformation than did expression of the full-length, annotated mRNA. The high incidence of APA in cancer cells, with consequent loss of 3′UTR repressive elements, suggests a pervasive role for APA in oncogene activation without genetic alteration.
MIT Department
Massachusetts Institute of Technology. Department of Biology
Terms of Use
Creative Commons Attribution-Noncommercial-Share Alike 3.0
Persistent DSpace Link
DOI of Published Version
https://doi.org/10.1016/j.cell.2009.06.016
